PABALDRATE PABALDRATE MALSIM COOLANT-S COOLANT-S WYDRATE PLUS WYDRATE PLUS LOSPAN PLUS WYDAL PLUS WYDAL PLUS MALOXID MALOXID MAGADRATE PLUS VALOMAG ACID OFF BANACID-S BANACID-S SIMILO

Dose: 2 g
Single Dose: 2 (2)
Frequency: 24 hourly
Route: PO
Instructions:

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

belongs to Metal Hydroxidesulphate. It belongs to Antacids pharmacological group.The Molecular Weight of Magaldrate is 1097.30.

Magaldrate is contraindicated in conditions like Kidney disease,Hypersensitivity to any component of product.

The severe or irreversible adverse effects of Magaldrate, which give rise to further complications include Nausea, Vomiting, Rashes, Muscular weakness, Hives.The symptomatic adverse reactions produced by Magaldrate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Diarrhea, Constipation, Intestinal pain.

Magaldrate is primarily indicated in conditions like Gastritis, Hyperacidity, Reflux oesophagitis.

No data regarding the interactions of Magaldrate was found.

Drug should not be given to patients suffering from Kidney dysfunction.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Susp Protect from Sunlight and Heat. Tab, Caps Store Below 40°C. Protect from Sunlight and Heat.

Magaldrate should be used only if clearly needed during pregnancy. It should be used with caution in patients with any pre-existing stomach disorders, kidney disease or allergy.